SNCA and Parkinson disease: In one study, RT-QuIC-identified pathogenic α-synuclein in the cerebrospinal fluid (CSF) had a sensitivity of 95% and a specificity of 98% in discriminating PD, DLB, and idiopathic RBD from controls, atypical parkinsonian disorders and Alzheimer’s disease [57].